How much funding has Mel-Mont Medical raised?

Mel-Mont Medical has disclosed $10.2M raised across 3 rounds.

Where is Mel-Mont Medical headquartered?

Mel-Mont Medical is headquartered in Doral, US.

Mel-Mont Medical

Doral, US · Founded 2020 · Delaware corporation

Mél Mont Medical develops a self-collection vaginal sampling device called Mía for cervical cancer screening that detects high-risk HPV DNA and active oncogenic E6/E7 mRNA overexpression without a speculum. The test is designed for women over 25 and provides actionable results to guide follow-up treatment decisions and prevent unnecessary procedures.

Biotech Digital Health FemTech Healthtech Medical Devices

Founders & leadership

Octavio Gonzalez ParedoExecutive

Michael TorresExecutive

Frank MelendezNamed on SEC filing

Liliana MontesNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$10.2M disclosed across 3 rounds · 2020–2025

▶$250KraisedDec 2025 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michael TorresExecutive Officer
Octavio Gonzalez ParedoExecutive Officer, Director
Liliana MontesExecutive Officer, Director
Frank MelendezExecutive Officer, Director

Offering amount: $5M
Amount sold: $250K
Minimum investment: $25K
Proceeds to insiders: $450K
First sale: Dec 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.9MraisedDec 2025 · 69 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Octavio Gonzalez ParedoExecutive Officer, Director
Frank MelendezExecutive Officer, Director
Michael TorresExecutive Officer
Liliana MontesExecutive Officer, Director

Offering amount: $7.5M
Amount sold: $6.9M
Minimum investment: $25K
Finders' fees: $50K
Proceeds to insiders: $950K
First sale: Aug 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3MraisedNov 2020 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Liliana MontesExecutive Officer, Director
Frank MelendezExecutive Officer, Director
Octavio Gonzalez ParedoExecutive Officer, Director

Offering amount: $3M
Amount sold: $3M
First sale: Oct 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Labcorp6 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.

Companies competing with Mel-Mont Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Our Work - Animation Video for Mel-Mont Medical - Global Media Deskglobalmediadesk.com · Feb 2024

Frequently asked questions

What does Mel-Mont Medical do?: Mél Mont Medical develops a self-collection vaginal sampling device called Mía for cervical cancer screening that detects high-risk HPV DNA and active oncogenic E6/E7 mRNA overexpression without a speculum. The test is designed for women over 25 and provides actionable results to guide follow-up treatment decisions and prevent unnecessary procedures.
How much funding has Mel-Mont Medical raised?: Mel-Mont Medical has disclosed $10.2M raised across 3 rounds.
Where is Mel-Mont Medical headquartered?: Mel-Mont Medical is headquartered in Doral, US.